Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma

Background and Objective: Understanding the tumor microenvironment (TME) and immune cell infiltration (ICI) may help guide immunotherapy efforts for colon cancer (COAD). However, whether ARID1B is truly regulated by hypermethylation or linked to immune infiltration remains unknown. The current work...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldi, Salem, He, Yun, Ivanov, Igor, Khamgan, Hassan, Safi, Mohammed, Alradhi, Mohammed, Shopit, Abdullah, Al-Danakh, Abdullah, Al-Nusaif, Murad, Gao, Yaping, Tian, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614077/
https://www.ncbi.nlm.nih.gov/pubmed/36313455
http://dx.doi.org/10.3389/fgene.2022.914354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614077/
https://www.ncbi.nlm.nih.gov/pubmed/36313455
http://dx.doi.org/10.3389/fgene.2022.914354

Ejemplares similares